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Hypertension and proteinuria: Long-term sequelae of uninephrectomy
in humans. Renal function and blood pressure were assessed in 52 renal
allograft donors 10 years or more following uninephrectomy, and their
current function compared to their pre-uninephrectomy function as well
as to age- and sex-matched control subjects consisting of inpatient
potential renal donors and a normal "outpatient" population. The
results show no significant deterioration in renal function as determined
by serum creatinine or creatinine clearance, as a function of years post-
uninephrectomy or age at the time of donation. A higher incidence of
proteinuria and hypertension was found in male donors as compared to
their pre-uninephrectomy values and to age- and sex-matched, inpatient
and outpatient control subjects. Female donors had increased protein-
uria when compared to pre-uninephrectomy and to age-matched, inpa-
tient potential donors. However, the extent of proteinuria and hyper-
tension was not significantly different from outpatient age-matched
females with two kidneys. In our population, uninephrectomy is
associated with mild proteinuria and hypertension.
Hypertension et proteinurie: Sequelles a long terme de l'uninéphrecto-
mie chez I'homme. La fonction rénale et Ia pression artérielle ont été
mesurées chez 52 donneurs d'allogreffons de rein, 10 ans ou plus apres
uninéphrectomie, et cette fonction comparée a leur fonction avant
uninéphrectomie, ainsi qu'à des sujets contrôles d'âge et de sexe
identiques, correspondant a des donneurs de rein potentiels hospita-
uses, et a une population normale "ambulatoire." Les résultats ne
montrent pas de détérioration significative de Ia fonction rénale,
mesurée par Ia créatininémie ou Ia clearance de Ia créatinine, en
fonction des années depuis l'uninéphrectomie, ou l'âge au moment du
don. Une incidence plus élevée de protéinurie et d'hypertension a été
trouvée chez les donneurs masculins par rapport a leurs valeurs avant
uninéphrectomie, et aux sujets contrôles hospitalisés ou ambulatoires
d'âge et de sexe identiques. Les donneuses avaient une protéinurie
augmentée lorsqu'elles étaient comparées aux valeurs avant uninéph-
rectomie, et aux donneuses potentielles, hospitalisees, de même age.
Cependant, Ia fréquence de Ia protéinurie et de l'hypertension ne
différait pas significativement des femmes ambulatoires d'ãge identique
ayant leurs deux reins. Dans notre population. l'uninéphrectomie est
associée avec une proteinurie et une hypertension moderees.
Extensive renal ablation in animals leads to progressive
azotemia, proteiriuria, and glomerulosclerosis [1—51. Experi-
ments have shown that when renal mass is reduced, the
remaining nephrons undergo functional, as well as structural,
hypertrophy [6, 7]. Hostetter et al [3] demonstrated that follow-
ing extensive ablation, single nephron glomerular filtration rate
of the remnant nephrons increases due to an increase in
glomerular capillary hydraulic pressure, as well as an increase
in glomerular capillary plasma flow rate. Early morphological
lesions in these glomeruli include endothelial and epithelial
damage, as well as increased mesangial matrix [2, 3]. These
early changes are eventually followed by the development of
glomerulosclerosis [2, 3], with a rapidity related to the degree of
renal ablation [5].
Kiprov, Colvin, and McCluskey 18] recently documented
significant proteinuria and hypertension in individuals with
unilateral renal agenesis. Light microscopy of renal biopsy and
necropsy specimens from these individuals showed findings
consistent with focal and segmental glomerulosclerosis in all of
the renal samples examined. In contrast, no focal sclerosis was
detected in autopsy specimens of ten patients who died 8 to 46
years following uninephrectomy [8]. Other long-term studies of
renal function in humans following uninephrectomy are scant.
Kohler [91 followed 105 patients post-uninephrectomy and
found hypertension in 55% of these patients and a reduced
creatinine clearance in 10%. However, the specific diseases for
which these patients underwent uninephrectomies were not
defined. More recently, a study of 24 patients who underwent
nephrectomy for unilateral renal disease documented the subse-
quent development of proteinuria, predominantly in males; in
four patients with post-nephrectomy proteinuria, renal biopsy
specimens showed the presence of focal and segmental sclerosis
in 10 to 25% of glomeruli [10]. Other studies have shown that
the survival of patients with uninephrectomy, excluding pa-
tients with abnormal serum urea or creatinine levels at the time
of nephrectomy, was not significantly different from those of
the normal population up to 20 years post-uninephrectomy [11,
12]. However, renal function was not assessed in these studies.
Published follow-up data of renal transplant donors has been
limited to 4 years and showed a mean decrease in the total
glomerular filtration rate (GFR) by 30% immediately postdona-
tion, which persisted up to 4 years post-uninephrectomy [13—
18]. However, longer term follow-up of renal function, protein-
uria, and blood pressure (BP) in donors post-uninephrectomy is
not available. For this reason, we undertook to evaluate renal
transplant donors more than 10 years after donation to assess
the long-term sequelae of uninephrectomy.
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Methods
Sixty kidney donors more than 10 years post-uninephrectomy
were identified from the Brigham and Women's Hospital Trans-
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plant Registry, Boston, Massachusetts. All donors contacted
were alive and well, Fitly-two agreed to participate in this
outpatient study. Serum creatinine and 24-hr urine collections
were obtained for determination of creatinine clearance and
protein excretion rate. Urine collection was usually on a
nonworking but otherwise fully ambulatory day. A fresh urine
sample was also obtained and examined immediately. BP was
obtained three times: at the beginning of the interview (which
was most often in the subject's home), just prior to venipunc-
ture, and at the end of the interview, The mean of these BP
readings was calculated. Pre-nephrectomy data were obtained
from a review of hospital charts.
Data for control subjects, matched for sex and current donor
age, were obtained from charts of other patients admitted for
kidney donor work-up evaluation. Thus, this control population
closely matched the donor study population in clinical and
biochemical parameters. Admission BPs were used for compar-
ison with the current BPs of the donor population. Urine
collections were performed on day 2 of admission, when the
patients were fully ambulatory. In addition, outpatient normal
control subjects were also evaluated for BP, creatinine clear-
ance, and proteinuria by methods similar to the donor
evaluation.
Adequacy of urine collection was assessed by quantitating
total creatinine excretion adjusted for body weight and compar-
ing it to published data of normal individuals [19, 201. All values
were within 2.0 SD of these published values. Creatinine
clearances were adjusted for body surface area. Quantitative
urine protein excretion was determined by precipitation with
sulfosalicylic acid after clearing the urine of phosphates with
acetic acid. The turbidity produced is measured against a
reference standard on a spectrophotometer. The lower limit of
detection of this assay is 3 mgldl; no urine sample was below
this limit. Statistical significance was determined by Fischer's
exact test. Linear regression analysis and the correlation coeffi-
cient and statistical significance were calculated using the
CLINFO (Rand, Santa Monica, California) data analysis sys-
tem. Values of all parameters except proteinuria were normally
distributed by the Kolmogorov-Smirnov distribution test and
are expressed as mean l.0 SD.
Results
The characteristics of the donors are shown in Table 1. Forty-
one patients were evaluated from 10 to 15 years post-unineph-
rectomy, and II were evaluated 15 years or more following
uninephrectomy. Potential donors used as control subjects, as
well as "outpatient" normal control subjects, had very nearly
the same mean age as those of the donors at the time of follow-
up (Table 1).
Table 2 is a composite of the data for subgroups of donors by
years post-uninephrectomy. Current serum creatinine concen-
trations (Scr) of donors plotted against years post-uninephrec-
tomy are shown in Figure 1. The correlation coefficient was r =
0.07 (P > 0.6), indicating the lack of a trend of the serum
creatinine concentration as a function of years post-uninephrec-
tomy. This lack of correlation was also evident when males (r =
0.01) or females (r = 0.17) were considered separately.
Current serum creatinine concentrations as a function of the
age of the donor at the time of donation are shown in Figure 2
and indicate that there is no evidence that serum creatinine
Table 1. Age distribution of renal donors and control subjects
Age at time of
donation, years Current age, years
Mean Range Mean Range
Donors
Men 39.8 13.5 (19 to 68) 53.6 13.5 (31 to 80)
N = 29
Women 41.8 15.0 (21 to 80) 61.0 14.8 (37to9l)N = 23
Control subjects
Age- and sex- matched inpatients
(potential donors)
Men 53.1 (32 to 71)
N = 29
Women 57.3 (37 to 77)
N = 22
"Outpatient" normal control subjects
Men 52.3 (32 to 69)
N=6
Women 55.6 (32 to 71)
N = 10
concentration is strongly related to the age of the donor at the
time of donation (r = 0.25, P = 0.07).
The ratio of current donor serum creatinine concentration
compared to pre-nephrectomy serum creatinine concentration
has a mean value of 1.23 0.29 for all patients (1.30 0.33 for
men and 1.18 0.24 for women). These ratios were different
from unity by the Wilcoxon signed rank test (P  0.01, see
Table 2). Similarly, the ratio of creatinine clearance (Ccr) pOst
nephrectomy to pre-nephrectomy, shown in Table 2 and Figure
3, as a function of years post-nephrectomy averaged 0.84 0.25
for 44 donors in whom pre-nephrectomy creatinine clearances
were available (different from unity by the Wilcoxon signed
rank test, P  0.01). However, eight donors (18%) had post/pre-
nephrectomy Ccr values of less than or equal to 0.6, and of
these, four (9%) had a ratio of less than or equal to 0.5. These
low ratios did not appear to be a function of years of follow-up
or of age of the donor at the time of uninephrectomy. Of interest
is that the current creatinine clearance of the donors decreased
as a function of age (r =
—0.59, P  0.01). The regression
equation of Cr in ml/min/l.73 m2 was 95.9 —0.8 age.
The ratio of current serum creatinine concentration of donors
to that of age- and sex-matched control subjects is shown in
Table 3. The mean of this ratio was 1.35 0.34 for women and
1.25 0.29 for men; the overall mean was 1.29 0.31. Again,
there was no correlation of this ratio as a function of years post-
nephrectomy.
The creatinine clearance (Ccr) of the donors compared to
those of age- and sex-matched control subjects, both adjusted
for body surface area, is also shown in Table 3. Of 44 donor-
control pairs in whom C- was available, seven (16%) had a
ratio of 0.6 or less (three females, four males).
Total 24-hr urinary protein excretion of donors as a function
of years post-nephrectomy is shown in Table 2 and Figure 4.
Prior to uninephrectomy, all donors were screened for protein-
uria and were excreting less than 50mg of protein/day. Thirteen
donors (nine men, four women) currently exhibit 24-hr urinary
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Table 2. Parameters of renal function of 52 donors post-uninephrectomy
Years
post-uninephrectomy
10
12
13
14
IS
16
17
18
19
20
26
28
Sr
N mgldl
12 1.29 0.31
12 1.15 + 0.22
II 1.23 0.10
3 1.30±0.06
3 1.03±0.61
4 1.35 0.64
1.8
1 1.2
1 1.7
1.3
1 1.3
1 1.2
I 1.4
Sr post N,
N Sr pre N,
1.26 0.27
1.23 0.22
1.13 0.12
1.19 0.08
1.20, 1.11
1.42 0.76
1.44
1.50
1.36
1.18
0.83
Cr post N,
N CcrpreN, N
10 0.72 0.20
12 0.88 0.27
8 1.07 0.17
2 0.56, 0.67
3 0.81 0.17
4 0.86 + 0.43
I 0.39
I 0.79
1 0.69
1 0.64
1 0.66
Urinary protein
excretion
mg/24 hr
110 169
153 83
188 163
479 469
126± 68
331 -- 401
25
370
301
Is
203
20
502
excretions above 250 mg/24 hr. Four donors had protein excre-
tions over 500 mg124 hr; of these, three were males. The highest
protein excretion (I g124hr) was found in a patient who became
an insulin-dependent diabetic patient 7 years following donation
to a non-diabetic sibling. We failed to observe a trend in the
degree of proteinuria with years post-nephrectomy (r =0.18, P
> 0.2). However, it should be recalled that the number of
patients with follow-up 15 years or more following uninephrec-
tomy is small (11) and may account for this lack of statistical
trend. Mean proteinuria in donors (188 211 mg/24 hr) was
significantly higher than in age- and sex-matched potential
donors (P < 0.01) (Table 4). This was true independent of
whether or not we included the diabetic patient with the highest
degree of proteinuria in the analysis. However, whereas mean
proteinuria for male donors (212 231 mg/24 hr) was signifi-
cantly greater than in outpatient male control subjects (P <
0.01), the difference for females did not achieve statistical
significance (P > 0.3). Mean proteinuria in donors 15 or more
years post-uninephrectomy was greater than in those less than
15 years (Table 4); however, these differences did not achieve
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Fig. 1 Current serum creatinine concentration (mgldl) of donors versus
years post-uninephrectomy. Symbols are: •, male (N = 29); A, female(N = 23).
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Fig. 2. Current serum creatinine concentration (mg/dI) versus age at
time of donation. Symbols are: •, male (N = 30); A, female (N = 23).
statistical significance for male (P = 0.09) or female donors (P
> 0.2).
The prevalence of hypertension in donors at the time of
follow-up is shown in Table 5. For men, 18 of 29 (60%) had a
diastolic pressure equal to or exceeding 90 mm Hg, and of these
18, 6 had diastolic BPs greater than or equal to 100 mm Hg.
Seven of 23 women (30%) were hypertensive with diastolic
pressures greater than 90 mm Hg, and two had diastolic BPs
greater than 100mm Hg. The prevalence of hypertension of the
inpatient age- and sex-matched potential donors, taken as the
admission BP. is also shown in Table 5. Eight of 29 men (28%)
and three of 22 women (14%) had diastolic BPs greater than 90
mm Hg. In the outpatient control population, one of six men
(17%) and two of ten women (20%) had diastolic BPs greater
than 90 mm Hg. Although the number of the outpatient control
population is small, the prevalence of hypertension in these
control subjects is similar to that found in the general popula-
tion [21].
The prevalence of hypertension post-uninephrectomy was
significantly higher than pre-uninephrectomy for men (P
0.003), but not for women (P — 0.1). Hypertension at the time of
follow-up was also significantly more in male donors than
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Years
postuni-
nephrectomy N
Current Sr donors
Current Scr controls N
Current Ccrdonors
Current C. controls
10 12 1.34 0.33 12 0.86 0.31
II II 1.17 0.19 8 1.09 0.38
12 10 1.20 0.17 9 1.17 0.41
13 3 1.49±0.31 2 0.51,0.82
14 3 1.35 0.23 3 0.90 0.35
15 4 1.47 0.69 4 0.80 0.41
16 1 1.80 I 0.51
17 1 1.20 1 1.24
18 1 1.42 1 1.10
19 1 1.41 1 0.60
20 1 0.93 — —
26 1 1.58 1 0.64
28 1 1.22 I 1.15
among inpatient control subjects (P = 0.02). In women, there
was no significant statistical difference in hypertension post-
uninephrectomy when compared to inpatient potential donors(P = 0.28) or outpatient control subjects (P > 0.5).
Of interest is that of the 25 currently hypertensive donors,
four (16%) were also hypertensive at the time of donation.
Conversely, of the seven donors with admission diastolic BPs
greater than 90 mm Hg at the time of donation, four remained
hypertensive, whereas three had diastolic BPs less than 90 mm
Hg at the time of the present evaluation.
There was also a relationship between the donors who
developed proteinuria and hypertension. Thus, of the 13 pa-
tients who developed proteinuria to greater than 250 mg/24 hr,
seven (54%) were also hypertensive. Conversely, of the 25
patients who are currently hypertensive, seven (28%) had
proteinuria greater than 250 mg124 hr. However, this correlation
was not statistically significant (x2 = 0.23, P = 0.636).
>-
a)
10 11 12 13 14 15 16 17 18 19 20 26 27 28 29
Years postuninephrectomy
Fig. 4. Urinary protein excretion (24-hr) of donors versus years post-
uninephrectomy. Symbols are: •, male (N = 28); , female (N = 23).
Discussion
Assessments of the risk of uninephrectomy to the donor were
historically based on life insurance actuarial data and surveys
[22, 23]. These limited data indicated that uninephrectomy did
not represent an increased survival risk. Morbidity of the
uninephrectomy procedure is considered to be minor at present
[24—26], and the long-term risk of renal donation in terms of
renal failure also appears to be small, since there is only one
reported case of a donor who became dialysis-dependent fol-
lowing an acute onset of hemolytic-uremic syndrome, although
other unreported cases are known to exist [27].
Although the number of donors evaluated 15 or more years
after uninephrectomy in this study is small, the results do not
reveal major adverse effects on renal function of donors as
assessed by serum creatinine concentration, or GFR as as-
sessed by creatinine clearance up to 28 years post-uninephrec-
tomy. Thus, the mean post-nephrectomy creatinine clearance
was 85% of the mean pre-nephrectomy Ccr in 44 donors in
whom these values were available. This value is higher than the
mean ratio of post- to pre-clearance found by Ogden [14] in 17
donors, which may be due to the fact that he measured inulin
clearances, which are generally lower than creatinine clear-
ances when GFR is less than normal, perhaps due to an adaptive
increase in the ability of the hypertrophied remaining kidney to
secrete creatinine [28]. The discrepancy may also be due to the
longer term follow-up in this study. Serial measurements of
renal donors have shown a trend toward progressive increase in
GFR for 4 years post-uninephrectomy [16]. Thus, a gradual,
long-term increase in GFR may occur in the hypertrophied
remaining kidney. In this regard, it is interesting to note that in
women with uninephrectomy, GFR, as measured by CCr,
increases as expected during pregnancy, indicating that the
remaining kidney is capable of further functional hypertrophy
[29, 30]. Other recent preliminary reports have also found a lack
of major adverse effects in terms of serum creatinine concentra-
tion in donors with follow-up to 18 years post-uninephrectomy
[31, 32].
Current Cr of donors declined with the current age of the
donor. Of interest is that the regression equation of the relation-
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Fig. 3. Ratio of creatinine clearance post-uninephrectomy to pre-
uninephrectomy in donors versus years post-uninephrectomy. Symbols
are: S. male (N = 23);, female (N = 21).
Table 3. Comparison of renal function of donors with age- and sex-
matched inpatient control subjects
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Table 4. Proteinuria in donors and control subjects
Control subjects
Age- and sex-matched inpatients (potential donors)
Men
N = 29
Women
N = 22
"Outpatient" normal control subjects
Men
N= 6
Women
N = 10
(28 to 1012)
N = 22
(26 to 261)
N = 19
(25 to 635)N=7
(15 to 918)N=4
Table 5. Prevalence and incidence of hypertension
Diastolic BP, mm Hg
90 I00
Donors
At time of donation
Men 5(18%) 0
N = 27
Women 2 (10%) 1 (5%)
N = 20
Current
Men 18 (60%) 6 (20%)
N = 29
Women 7 (30%) 2 (9%)
N = 23
Control subjects
Age- and sex-matched inpatients
(potential donors)
Men 8 (28%) 2 (7%)
N = 29
Women 3 (14%) 2 (9%)
N = 22
Outpatient" normal control subjects
Men 1(17%) 1(17%)N=6
Women 2 (20%) —
N = 10
ship of creatinine clearance and age yields an age-dependent
factor (0.8) identical to that found by Rowe et al [20] in a large
series of normal volunteers, suggesting that uninephrectomy
does not lead to an acceleration of the rate of decline Of C- with
age.
Comparison of current donor serum creatinine concentration
and creatinine clearance to age- and sex-matched control sub-
jects also suggests that the functional and hemodynamic adapta-
tion to uninephrectomy seen in animals does not lead to an
adverse effect on renal function in humans within the first 2 to 3
decades after donation. The overall ratio of serum creatinine
and Ccr of donors to those of age- and sex-matched control
subjects averaged 1.29 0.31 and 0.94 0.35, respectively. No
dependence of this ratio on years post-uninephrectomy was
evident from our data, suggesting that the change in renal
function post-nephrectomy in our data may also partly reflect
the normal aging process [20]. The percentage of patients with
ratios of Cr of less than or equal to 0.6 in our data (18%) is also
similar to that found by Ogden [141(17%) after a mean follow-up
of 3 years, and was again independent of years post-uninephrec-
tomy or of age of the donor at the time of uninephrectomy, in
contrast to animal studies [33, 34].
The current data do show that there is a higher incidence of
proteinuria in patients who have undergone uninephrectomy.
Twenty-three percent had proteinuria greater than 250 mg124 hr
and 8% had proteinuria greater than 500 mg124 hr. Lacking
histologic material, the glomerular or tubular lesion(s) responsi-
ble for proteinuria following organ donation remain to be
defined [35]. Although proteinuria has been noted in animals
subjected to extensive renal ablation and was a precursor of
eventual glomerular structural changes [3, 36, 37], we observed
no correlation between the degree of proteinuria and years
postnephrectomy. However, the numbers of patients in each
year of follow-up are relatively small, and a statistical trend may
not be evident. The higher incidence and prevalence of protein-
uria in the male donor population is also consistent with the
experimental observation that uninephrectomy leads to a great-
er magnitude of proteinuria in male than in female rats [38, 39]
and with the recently observed predilection for proteinuria to
develop in male patients following uninephrectomy for unilater-
al renal disease [10].
The greater prevalence of hypertension in male donors,
defined as diastolic pressure greater than 90 mm Hg and
measured under equivalent conditions to controls, is consistent
with the findings of a higher prevalence of hypertension in
males than in females among the general population [21]. Thus,
the prevalence of hypertension in white males in the same age
group as the current age of male donors is 16.7%, while in white
Donors
Men
N = 29
Women
N = 23
<15 Years post-nephrectomy
Mean
mg/day
Range Mean
l5 Years post-nephrectomy
209 250
130± 77
mg/day
Range
272 220
303 425
<50
<50
63
158
(22 to 103)
(37 to 278)
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females in the same age group as the current age of female
donors it was 10.8% [211. The same study also noted that the
proportion of men with higher diastolic pressures (greater than
100 mm Hg) is almost twice that for women, again similar to our
data in donors and the control population. The higher preva-
lence of hypertension in renal allograft donors is also consistent
with recent data on donors by others [31, 40] and with the
experimental observation that unilateral nephrectomy causes
an even greater elevation in BP of spontaneously hypertensive
rats [41]. A correlation between kidney size and hypertension
has also been noted in humans [42].
Familial renal disease, with variable expressions in the donor
and recipient, could account, at least in part, for the increased
prevalence of hypertension and proteinuria among donors.
However, of 24 donor-recipient pairs in the present study in
whom HLA typing was available, II had hypertension, and of
these II, only two were HLA identical whereas the remaining
nine shared only one haplotype. The prevalence of the specific
HLA types in these patients was not different from that of the
general population [43].
In summary, evaluation of 52 patients at least 10 years
following unilateral nephrectomy for living related renal trans-
plantation indicates no significant deterioration of GFR, but a
higher prevalence of hypertension and proteinuria, particularly
in males. In contrast to animal studies, we observed no correla-
tion between age at the time of donation and subsequent renal
function. However, the small number of patients with greater
than 15 years of follow-up must qualify this conclusion. Similar
long-term follow-up studies should be performed in other
centers to evaluate the extent and significance of these potential
long-term complications following elective renal donation.
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